Cellular toxicity and apoptosis studies in osteocarcinoma cells, a comparison of177 Lu-EDTMP and Lu-EDTMP

Current Radiopharmaceuticals

Volumn 6, Issue 3, 2013, Pages 146-151

  Kumar, Chandan ^a   Korde, Aruna ^a   Kumari, Kusum V ^a   Das, Tapas ^a   Samuel, Grace ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

Apoptosis; Bone mineralization; Cell uptake; Cellular toxicity; Osteocarcinoma

Indexed keywords

EDTMP LU; EDTMP LU 177; LACTATE DEHYDROGENASE; LUTETIUM; LUTETIUM 177; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BCL 2; RADIOPHARMACEUTICAL AGENT; TRYPAN BLUE; UNCLASSIFIED DRUG; LUTETIUM ETHYLENEDIAMINETETRAMETHYLENE PHOSPHONIC ACID; ORGANOMETALLIC COMPOUND; ORGANOPHOSPHORUS COMPOUND; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

APOPTOSIS; ARTICLE; BONE CANCER; BONE MINERALIZATION; CARCINOMA CELL; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA FRAGMENTATION; DOWN REGULATION; DRUG BINDING; DRUG EFFECT; ENZYME RELEASE; ISOTOPE LABELING; MTT ASSAY; OSSIFICATION; OSTEOCARCINOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION DOSE; WESTERN BLOTTING; CELL SURVIVAL; CHEMISTRY; COMPARATIVE STUDY; HUMAN; METABOLISM; OSTEOSARCOMA; PATHOLOGY; SCINTISCANNING; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DNA FRAGMENTATION; HUMANS; L-LACTATE DEHYDROGENASE; ORGANOMETALLIC COMPOUNDS; ORGANOPHOSPHORUS COMPOUNDS; OSTEOSARCOMA; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIOPHARMACEUTICALS; TETRAZOLIUM SALTS; THIAZOLES; TRYPAN BLUE;

EID: 84892449400     PISSN: 18744710     EISSN: 18744729     Source Type: Journal    
DOI: 10.2174/18744710113069990021     Document Type: Article

References (20)

1. 177Lu-EDTMP: a viable bone pain palliative in skeletal metastasis. Cancer Biother. Radiopharm., 2008, 23(2), 202-213.
2. 177Lu-EDTMP, a potential bone pain palliation agent. Nucl. Med. Biol., 2010, 37, 215-226.
3. Stefan, T.; Oskar, H.; Wolfgang, W.; Dagmar, E.; Leonhardk, M.; Karoline, W.; Joseph, N.; Helmut, V.; Kurt, K.; Robert, D.; Markus, M.; Uptake of bone-seekers is solely associated with mineralisation! A study with 99mTc-MDP, 153Sm-EDTMP and 18F-fluoride on osteoblasts. Eur. J. Nucl. Med. Mol. Imaging, 2006, 33, 491-494.
4. Mitterhauser, M.; Toegel, S.; What to consider in the development of new bone seekers: mechanistic and tracer-related aspects. Nucl. Med. Biol., 2008, 35, 817-824.
5. Elmore, S.; Apoptosis:A review of programmed cell death. Toxic Pathol., 2007, 35, 495-516.
6. Friedman, A.H.; Radiation induced signal transduction and stress response. Radiat. Res., 1998, 150, S102-108.
7. Lei, L.; Story, M.; Legerski, R.J.; Cellular responses to ionizing radiation damage. Int. J. Radiat. Oncol. Biol. Phys., 2001, 49, 1157-1162.
8. Szumiel, I.; Ionizing radiation induced cell death. J. Radiat Biol., 1994, 66, 329-341.
9. Ringdahl, M.H.; Nicotera, P.; Radford, I.R.; Radiation induced apoptosis. Mut. Res., 1996, 366, 171-179.
10. Cory, S.; Huang, D.C.S.; Adams, J.M.; The Bcl-2 fanily: role in cell survival and oncogenesis. Oncogene, 2003, 22, 8590-8607.
11. Mirkovic, N.; Meyn, R. E.; Hunter, N. R.; Milas L; Radiation unduced apoptosis in murine lymphoma in vivo. Radiother. Oncol., 1994, 33, 11-16.
12. Vignesh, R.C.; Djody, S.S.; Jayasudha, G.; Ilangovan, R.; Balaganesh, M.; Veni, S.; Sridhar, S.; Effect of ethanol on human osteosarcoma cell proliferatation differentiation and mineralization. Toxicology, 2006, 220, 63-70.
13. Gregory, C.A.; Gunn, W.G.; Peister, A.; Prockop, D.J.; An Alizarin redbased assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem. 2004, 329, 77-84.
14. 177Lu-DOTMP as potential agents for palliative radiotherapy of bone metastasis. Appl. Radiat. Isotopes, 2008, 66, 1196-1205.
15. Schwartz; Jashovam Shani, W.; Aubrey, S.; Haifa T.; David, A.; Jona, S.; Uptake and Biodistribution of Technetium-99m-MD32P During Rat Tibial Bone Repair. J. Nucl. Med., 1993, 34, 104-108.
16. Sela, J.; Shani, J.; Kohavi, D.; Soskolne, W.A.; Itzhak, K.; Boyan, B.D.; Schwartz Z.; Uptake and biodistribution of 99mtechnetium methylene-[32P] diphosphonate during endosteal healing around titanium, stainless steel and hydroxyapatite implants in rat tibial bone. Biomaterials, 1995, 18, 1373-1380.
17. Mitterhauser, M.; Toegel, S.; Wadsak, W.; Mien, L.K.; Eidherr, H.; Kletter, K.; Viernstein, H.; Kluger, R.; Engel, A.; Dudczak, R.; Binding studies of [18F]-fluoride and polyphosphonates radiolabelled with [99mTc], [111In], [153Sm] and [188Re] on bone compartments: Verification of the pre vivo model. Bone, 2004, 34, 835-844.
18. Kinishi, D. 99mTc-MDP accumulation mechanism in bone. Oral. Surg. Oral. Med., 1993, 75, 239-46.
19. Nicolay, O.F.; Heeley, J.D.; Jeffcoat, M.K.; Jones, A.G.; Autoradiographic localization of technetium-99m methylene diphosphate in growth sites of young mice. Int. J. Rad. Appl. Instrum. B., 1998, 15, 152-63.
20. Kumar, C.; Pandey, B.N.; Samuel, G.; Venkatesh, M.; Cellular internalization and mechanism of cytotoxicity of 131I-rituximab in Raji cells. J. Environ. Pathol. Toxicol. Oncol., 2013, 6, 91-99.